New long-acting muscarinic antagonist-long-acting beta agonist users had a decreased risk for a first moderate/severe COPD ...

Escalating to extrafine single-inhaler triple therapy significantly reduces exacerbations in patients with moderate to severe COPD.

Researchers found that umeclidinium-vilanterol was associated with a lower risk for a first moderate or severe COPD exacerbation vs glycopyrrolate-formoterol. HealthDay News — Umeclidinium-vilanterol ...

Key opportunities in the drug delivery devices market include expanding digital health partnerships for innovative injectable and connected solutions, addressing chronic conditions like asthma and ...

Florida’s mild climate guarantees that something is in bloom almost constantly, and that goes double for allergies.

A doctor recently shared a striking case from the emergency room that has sparked widespread discussion online. The story highlights how a seemingly harmless over-the-counter medicine can interact ...

A plume of Saharan dust is set to sweep across the UK, with many urged to stay indoors over fears it could trigger coughing, wheezing or medical emergencies. Asthma sufferers and those with lung ...

As a prescription drug or a supplement, the antioxidant properties in NAC have varied uses, from reversing a Tylenol overdose ...

Explore MotoRX and its importance for riders managing medications. Understand how to stay safe while enjoying your ride.

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to the environment but can also lead to slightly ...

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to the environment but can also lead to slightly ...

Medication nonadherence among people with chronic obstructive pulmonary disease (COPD) is a result of affordability and lack of knowledge about medications, among other factors, and leads to increased ...